Paddock Laboratories rides herd on drugs other companies put out to pasture. The company develops and manufactures generic pharmaceuticals and OTC specialty products. Paddock's manufacturing capabilities include tablets, suppositories, powders, and semi-solid. Its product line includes antibiotics, antifungals, diabetes treatments, enemas, injectables, and dermatological offerings, as well as compounding bases and charcoal products. Along with manufacturing its own products, the company offers contract manufacturing services to other pharmaceutical firms. The company, which was founded in 1977, was acquired in 2011 by generics maker Perrigo for about $540 million.